Active Pharmaceutical Ingredient (API)

Caffeine Citrate (Neonatal)

Treatment of Apnea of Prematurity

A CNS stimulant that improves respiratory drive in premature infants prone to breathing pauses.
Technical Profile
Reference Code
CAF666
CAS Number
69-22-7
Molecular Weight
386.30 g/mol
Chemical Class
N/A
Molecular Formula
C14H18N4O9
Therapeutic Class
N/A

Verified Brands

Medicines containing Caffeine Citrate (Neonatal) as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.